[Cardiac resynchronization therapy (CRT)--a new option for severe heart failure].
The increasing incidence of heart failure is an important issue in cardiovascular medicine. Apart from pump failure, conduction disturbances and arrhythmias may play a major role and must be considered when selecting the therapy. In addition to optimal drug therapy, cardiac resynchronization (CRT) with biventricular stimulation offers a new therapeutic option.
Kiencke
S
S
Abteilung für Kardiologie, Universitätskliniken Basel.
Osswald
S
S
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial / Q000191:economics / Q000379:methods*; D002986:Clinical Trials as Topic; D017147:Defibrillators, Implantable; D004452:Echocardiography; D015150:Echocardiography, Doppler; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011379:Prognosis; D013902:Radiography, Thoracic; D012737:Sex Factors; D013997:Time Factors; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D010919:Placebos